From 2014 to 2018, our research partners in Latin American and Caribbean cities gathered information from people who use or sell smokable cocaine, in order to identify key patterns in the regional markets of smokable cocaine. The information and testimonials we gathered reveal a lack of policy responses beyond punitive measures. Meanwhile, myths and misunderstandings about smokable cocaine and its users prevail. Read on below as we attempt to debunk the four most common myths.
Smokable cocaines are commonly referred to as “the most harmful drug”, and considered not just a threat to public health, but also to public security in the urban centres of many large cities. As a result, its users are frequently subject to hostility and stigmatization.
The 63rd Sesssion of the Commission on Narcotic Drugs takes place from 2nd to 6th March 2020. TNI and its partners will participate at this annual series of meetings and co-hosts five side events on 5th and 6th March 2020.
Societies in the Americas have coexisted with smokable cocaines for over four decades, but - surprisingly - there is a dearth of research on the development of the market, or much first-hand evidence of how this substance is actually commercialized and used by millions of people in the region. After a few years of field research, our study on the topic will be launched at the Commission on Narcotic Drugs.
From 15 to 18 November 2018, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, on behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ) jointly organised the 10th Asian Informal Drug Policy Dialogue (IDPD). It was organised in collaboration with the Central Committee for Drug Abuse Control (CCDAC) of Myanmar and held at Inle Lake, Southern Shan State, Myanmar.
Local and regional authorities across Europe are confronted with the negative consequences of a persisting illicit cannabis market. Increasingly, local and regional authorities, non-governmental pressure groups and grassroots movements are advocating a regulation of the recreational cannabis market.
Tom Blickman, Katie Sandwell, Dania Putri, Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel
20 March 2019
In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.
This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches. Public Policy Exchange welcomes the participation of all key partners, responsible authorities and stakeholders. The Symposium will support the exchange of ideas and encourage delegates to engage in thought-provoking topical debate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Ecuador has entered a new era in drug policy and legislation. Twenty-five years after the last major legal reform, brought about by the famed Narcotic and Psychotropic Substances Law (Ley de Sustancias Estupefacientes y Psicotrópicas, Law 108), which took effect on September 17, 1990, the National Assembly is about to debate—for the second and final time—the draft Law on Prevention of Drugs and Use or Consumption of Substances Classified as Subject to Oversight (Ley de Prevención de Drogas y Uso y Consumo de Sustancias Catalogadas Sujetas a Fiscalización.)
Luxembourg's Parliament is to debate the decriminalisation of consumption of cannabis, the health minister said while outlining a new drug prevention programme. The minister said she hoped to raise awareness among young people of the risks surrounding cannabis consumption as well as the use of other, legal drugs, such as alcohol and tobacco.
Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
No fewer than six randomised controlled trials – in Switzerland, the Netherlands, Germany, Spain, Canada, and England – concluded that heroin assisted treatment is more effective than conventional treatments in a subgroup of heroin users.